Blog

Six months ago, you bought the ChatGPT Team licenses. Maybe you hired someone whose job title included the word "AI." You ran workshops. People started using the tools. And yet — look at the revenue line, look at the headcount, look at the three bottlenecks that were slowing you down in January. They are still there.

Small businesses buying AI in 2026 want done-for-you AI that runs on their behalf — not training, platforms, or toolkits that require internal expertise they don't have and weren't hired to build.

This distinction matters more than most AI vendors want to admit. The market is splitting cleanly into two buyer types: enterprises that want to build internal AI capability, and small-to-midsize businesses that want the outcomes AI delivers without becoming AI practitioners themselves. Most of the vendor ecosystem is selling to the first group while standing in front of the second.

The most common mistake in production agentic pipelines is treating AI agent evaluation as a single activity that happens at the output. It is not. Every inference step in a multi-stage pipeline is its own failure surface — its own input space, its own output contract, its own failure modes. Adding a guardrail prompt to the final model call and calling that "evaluation" is like putting a smoke detector only in the lobby of a building with twelve floors.

For a large share of healthcare organizations, Salesforce Health Cloud has quietly become the system of record for everything that is not the EHR: care coordination, patient and member outreach, intake, eligibility, prior authorization, referrals. It is the connective tissue between clinical systems and the humans who run operations around them. And in 2026, two separate AI questions are landing on the same desk at the same time.